Study highlights hydroxychloroquine risk

An analysis of 96,000 cases of COVID-19, published today in The Lancet, shows that patients who were treated with the antimalarial drugs chloroquine or hydroxychloroquine had a death rate that was roughly twice as high as for patients who weren’t.

Get the news brief on GeekWire.

By Alan Boyle

Mastermind of Cosmic Log, contributor to GeekWire and Universe Today, author of "The Case for Pluto: How a Little Planet Made a Big Difference," past president of the Council for the Advancement of Science Writing.

Leave a Reply

%d bloggers like this: